{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:35:42Z","timestamp":1778877342255,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bulcan.2021.06.014","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T08:24:04Z","timestamp":1634286244000},"page":"642-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of intracavitary administration of elemene combined with nedaplatin on malignant pleural effusion"],"prefix":"10.1016","volume":"109","author":[{"given":"Ke Hong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2588-9726","authenticated-orcid":false,"given":"Yong Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue Mei","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2021.06.014_bib0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccm.2017.11.004","article-title":"Malignant pleural effusion: from diagnostics to therapeutics","volume":"39","author":"Asciak","year":"2018","journal-title":"Clin Chest Med"},{"issue":"8","key":"10.1016\/j.bulcan.2021.06.014_bib0160","article-title":"Malignant pleural effusion and its current management: a review","volume":"55","author":"Skok","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.bulcan.2021.06.014_bib0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000029240","article-title":"Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases","volume":"65","author":"Martinez-Moragon","year":"1998","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.bulcan.2021.06.014_bib0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0025-6196(11)60848-3","article-title":"Recent advances in the diagnosis and management of malignant pleural effusions","volume":"83","author":"Heffner","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.bulcan.2021.06.014_bib0175","first-page":"1169","article-title":"Molecular profiling of malignant pleural effusion in metastatic non-small-cell lung carcinoma. The effect of preanalytical factors","volume":"14","author":"Carter","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.bulcan.2021.06.014_bib0180","first-page":"3309","article-title":"Application of liposomal technologies for delivery of platinum analogs in oncology","volume":"8","author":"Liu","year":"2013","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"10.1016\/j.bulcan.2021.06.014_bib0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bulcan.2021.06.014_bib0190","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"10.1016\/j.bulcan.2021.06.014_bib0195","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1111\/cas.13772","article-title":"Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: a phase II study","volume":"109","author":"Ohnuma","year":"2018","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.bulcan.2021.06.014_bib0200","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.anl.2018.12.013","article-title":"Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma","volume":"46","author":"Okuda","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.bulcan.2021.06.014_bib0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphar.2020.00343","article-title":"The drug-resistance mechanisms of five platinum-based antitumor agents","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.bulcan.2021.06.014_bib0210","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem Rev"},{"issue":"8","key":"10.1016\/j.bulcan.2021.06.014_bib0215","doi-asserted-by":"crossref","first-page":"12091","DOI":"10.1002\/jcb.28624","article-title":"Regulation of signaling pathways by beta-elemene in cancer progression and metastasis","volume":"120","author":"Qureshi","year":"2019","journal-title":"J Cell Biochem"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.bulcan.2021.06.014_bib0220","first-page":"56","article-title":"Herbal extract elemene intrathoracic injection in the treatment of lung cancer patients with malignant pleural effusion: a meta-anaylsis","volume":"10","author":"Chen","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.bulcan.2021.06.014_bib0225","doi-asserted-by":"crossref","first-page":"108812","DOI":"10.1016\/j.biopha.2019.108812","article-title":"Molecular targets of beta-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: a review","volume":"114","author":"Zhai","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bulcan.2021.06.014_bib0230","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.2147\/IJN.S174527","article-title":"Drug delivery systems for elemene, its main active ingredient beta-elemene, and its derivatives in cancer therapy","volume":"13","author":"Zhai","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.bulcan.2021.06.014_bib0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fphar.2017.00105","article-title":"Beta-Elemene: mechanistic studies on cancer cell interaction and its chemosensitization effect","volume":"8","author":"Jiang","year":"2017","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.bulcan.2021.06.014_bib0240","first-page":"2561","article-title":"Betaelemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1AVEGFA pathway based on network pharmacology","volume":"42","author":"Zhu","year":"2019","journal-title":"Oncol Rep"},{"issue":"44","key":"10.1016\/j.bulcan.2021.06.014_bib0245","doi-asserted-by":"crossref","first-page":"e12542","DOI":"10.1097\/MD.0000000000012542","article-title":"Evaluation of the efficacy and safety of elemene in treating malignant pleural effusion caused by tumors: a PRISMA guided meta-analysis","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.bulcan.2021.06.014_bib0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1386-6532(00)00080-9","article-title":"Peripheral CD4+\/CD8+ T\u2212lymphocyte counts estimated by an immunocapture method in the normal healthy south Indian adults and HIV seropositive individuals","volume":"17","author":"Kannangai","year":"2000","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.bulcan.2021.06.014_bib0255","first-page":"319","article-title":"CD4\/CD8 lymphocyte counts in healthy, HIV-positive individuals & AIDS patients","volume":"124","author":"Ray","year":"2006","journal-title":"Indian J Med Res"},{"issue":"140","key":"10.1016\/j.bulcan.2021.06.014_bib0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev"},{"issue":"2","key":"10.1016\/j.bulcan.2021.06.014_bib0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3949\/ccjm.86a.17095","article-title":"Managing malignant pleural effusion","volume":"86","author":"Wahla","year":"2019","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.bulcan.2021.06.014_bib0270","doi-asserted-by":"crossref","first-page":"6723807","DOI":"10.1155\/2016\/6723807","article-title":"Combinatorial antitumor effect of rapamycin and beta-elemene in follicular thyroid cancer cells","volume":"2016","author":"Zhou","year":"2016","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.bulcan.2021.06.014_bib0275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12906-019-2544-2","article-title":"Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma","volume":"19","author":"Long","year":"2019","journal-title":"BMC Complement Altern Med"},{"issue":"Supplement","key":"10.1016\/j.bulcan.2021.06.014_bib0280","first-page":"C244","article-title":"A meta-analysis of elemene versus DDP intrapleural injection in the treatment of malignant pleural effusion caused by lung cancer","volume":"12","author":"Wang","year":"2016","journal-title":"J Cancer Res Ther"},{"issue":"4","key":"10.1016\/j.bulcan.2021.06.014_bib0285","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3892\/or.2012.1913","article-title":"B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites","volume":"28","author":"Cui","year":"2012","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.bulcan.2021.06.014_bib0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12031-010-9483-1","article-title":"Amelioration of experimental autoimmune encephalomyelitis by beta-elemene treatment is associated with Th17 and Treg cell balance","volume":"44","author":"Zhang","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.bulcan.2021.06.014_bib0295","doi-asserted-by":"crossref","first-page":"152787","DOI":"10.1016\/j.phymed.2018.12.010","article-title":"Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III\/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines","volume":"59","author":"Wang","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bulcan.2021.06.014_bib0300","doi-asserted-by":"crossref","first-page":"6892961","DOI":"10.1155\/2020\/6892961","article-title":"The antitumor efficacy of beta-elemene by changing tumor inflammatory environment and tumor microenvironment","volume":"2020","author":"Xie","year":"2020","journal-title":"Biomed Res Int"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745512100360X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745512100360X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:35:10Z","timestamp":1757792110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000745512100360X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S000745512100360X"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.06.014","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of intracavitary administration of elemene combined with nedaplatin on malignant pleural effusion","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer.","name":"copyright","label":"Copyright"}]}}